
To describe the difficulty in assessing the biological activity of a novel agent in phase II zzso 

Two major fields of research provide interesting new potential zzso zzso based on new imaging techniques zzso PET or spectral imaging that explore zzso zzso dynamic contrast enhanced zzso zzso or zzso that explore zzso zzso and zzso growth zzso and zzso zzso assessment of zzso burden across time, such as the growth zzso zzso 

Most of the recently described techniques appear attractive, but require formal zzso 

